| abstract |
The present invention relates generally to the field of diagnostics, and the prediction of mid- to long- term clinical outcomes for subjects with liver disease. In particular, the present invention provides a new liver test involving the use of a serum panel model and the development of an algorithm to reliably 5 predict liver related mid- to long-term clinical outcomes in chronic HCV infection, and in particular, in relation to liver related death, hepatocellular carcinoma (HCC) and decompensation. |